JN BIOTECH ApS: Financial statements 2025
CVR: 25325001
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
JN BIOTECH ApS (CVR 25325001) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 90,325 and a net result of DKK 104,408 compared with DKK 60,995 the year before. That is an increase of 222.3% compared with the year before. Equity in the 2025 report amounted to DKK 821,161. The solvency ratio was 61.8%.
- Gross Profit
- DKK 90,325
- Profit/Loss
- DKK 104,408
- Equity
- DKK 821,161
- Total Assets
- DKK 1,327,956
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 90K | 104K | 821K | 0 |
| 2024 | - | 28K | 61K | 717K | 0 |
| 2023 | - | 115K | 150K | 656K | 0 |
| 2022 | - | 82K | 338K | 3M | 0 |
| 2021 | - | 116K | 1.6M | 15.7M | 0 |
Official annual report
How creditworthy is JN BIOTECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout JN BIOTECH ApS
JN BIOTECH ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Andre personlige serviceydelser i.a.n.. The management consists of Jens Bredal Nielsen. The company is owned by JBN Biotech ApS. The company has 1 employee (2006). In 2025, the company reported a gross profit of DKK 90,325 and a net result of DKK 104,408 compared with DKK 60,995 the year before. Equity in the 2025 report amounted to DKK 821,161.